Company intelligence / Profile preview

Compass Capital

Ownership: Private
Development stage: Other

Overview

Compass Capital is a leading private equity firm focused on value investing across multiple sectors. While it is not itself a biotech or healthcare company, it has participated in transactions involving pharmaceutical and diagnostics companies as part of its investment activities.

Industry: Investors

Partnerships

Participated in acquisitions such as Tenth of Ramadan for Pharmaceuticals Industries and Diagnostics Reagents ("Rameda")

Beyond the preview

Go deeper on Compass Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compass Capital.

Explore the full profile